Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Total Current Liabilities (2017 - 2025)

Historic Total Current Liabilities for CollPlant Biotechnologies (CLGN) over the last 9 years, with Q3 2025 value amounting to $2.6 million.

  • CollPlant Biotechnologies' Total Current Liabilities fell 1423.92% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 1423.92%. This contributed to the annual value of $3.0 million for FY2024, which is 864.35% down from last year.
  • Per CollPlant Biotechnologies' latest filing, its Total Current Liabilities stood at $2.6 million for Q3 2025, which was down 1423.92% from $2.7 million recorded in Q2 2025.
  • CollPlant Biotechnologies' 5-year Total Current Liabilities high stood at $3.4 million for Q1 2024, and its period low was $2.3 million during Q3 2022.
  • Its 5-year average for Total Current Liabilities is $2.9 million, with a median of $2.9 million in 2023.
  • Per our database at Business Quant, CollPlant Biotechnologies' Total Current Liabilities surged by 3478.86% in 2021 and then tumbled by 2265.32% in 2022.
  • CollPlant Biotechnologies' Total Current Liabilities (Quarter) stood at $3.0 million in 2021, then rose by 3.02% to $3.1 million in 2022, then grew by 4.7% to $3.3 million in 2023, then decreased by 8.64% to $3.0 million in 2024, then decreased by 11.38% to $2.6 million in 2025.
  • Its Total Current Liabilities stands at $2.6 million for Q3 2025, versus $2.7 million for Q2 2025 and $2.7 million for Q1 2025.